PortfoliosLab logo

Allogene Therapeutics, Inc. (ALLO)

Equity · Currency in USD · Last updated Jun 23, 2022

Company Info

ISINUS0197701065
CUSIP019770106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$11.96
Year Range$6.78 - $27.64
EMA (50)$9.02
EMA (200)$13.67
Average Volume$2.19M
Market Capitalization$1.63B

ALLOShare Price Chart


Chart placeholderClick Calculate to get results

ALLOPerformance

The chart shows the growth of $10,000 invested in Allogene Therapeutics, Inc. on Oct 12, 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $4,784 for a total return of roughly -52.16%. All prices are adjusted for splits and dividends.


ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

ALLOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M59.89%-3.63%
YTD-19.84%-21.11%
6M-23.53%-19.13%
1Y-52.43%-11.00%
5Y-18.13%9.09%
10Y-18.13%9.09%

ALLOMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ALLOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Allogene Therapeutics, Inc. Sharpe ratio is -0.56. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

ALLODividend History


Allogene Therapeutics, Inc. doesn't pay dividends

ALLODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

ALLOWorst Drawdowns

The table below shows the maximum drawdowns of the Allogene Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Allogene Therapeutics, Inc. is 87.45%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.45%May 26, 2020496May 11, 2022
-45.29%Nov 7, 2018341Mar 18, 202037May 11, 2020378
-16.54%Oct 16, 20187Oct 24, 20187Nov 2, 201814
-7.25%May 12, 20202May 13, 20201May 14, 20203
-0.39%May 19, 20201May 19, 20201May 20, 20202

ALLOVolatility Chart

Current Allogene Therapeutics, Inc. volatility is 123.92%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Allogene Therapeutics, Inc.


Loading data...